18 Einträge gefunden

1. Post-injection delirium/sedation syndrome in patients treated with olanzapine pamoate: mechanism, incidence, and management

   1. Lüdecke, Daniel
   2. Schöttle, Daniel
   3. Karow, Anne
   4. Lambert, Martin
   5. Naber, Dieter

   2015 - Forschungsinformationssystem des UKE
2. Hamburger Modell der integrierten Versorgung von schwer erkrankten Psychosepatienten

   1. Lambert, Martin
   2. Schöttle, Daniel
   3. Bock, Thomas
   4. Schulte-Markwort, Michael
   5. Naber, Dieter
   6. Karow, Anne

   2014 - Forschungsinformationssystem des UKE
3. Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.

   1. Karow, Anne
   2. Moritz, Steffen
   3. Lambert, Martin
   4. Schöttle, Daniel
   5. Naber, Dieter
   6. Initiative, On Behalf Of The EGOFORS

   2012 - Forschungsinformationssystem des UKE
4. Remission as perceived by people with schizophrenia, family members and psychiatrists.

   1. Karow, Anne
   2. Naber, Dieter
   3. Lambert, Martin
   4. Moritz, Steffen
   5. Initiative, EGOFORS

   2012 - Forschungsinformationssystem des UKE
5. Differentiating schizoaffective and bipolar I disorder in first-episode psychotic mania.

   1. Schöttle, Daniel
   2. Schimmelmann, Benno G
   3. Conus, Philippe
   4. Cotton, Sue M
   5. Michel, Chantal
   6. McGorry, Patrick D
   7. Karow, Anne

   2012 - Forschungsinformationssystem des UKE
6. Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later.

   1. Lambert, Martin
   2. Karow, Anne
   3. Leucht, Stefan
   4. Schimmelmann, Benno G
   5. Naber, Dieter

   2010 - Forschungsinformationssystem des UKE
7. Early- and delayed antipsychotic response and prediction of outcome in 528 severely impaired patients with schizophrenia treated with amisulpride.

   1. Lambert, Martin
   2. Schimmelmann, B G
   3. Naber, Dieter
   4. Eich, F-X
   5. Schulz, Holger
   6. Huber, C G
   7. Karow, Anne

   2009 - Forschungsinformationssystem des UKE
8. Subjective wellbeing under quetiapine treatment - effect of diagnosis, mood state, and anxiety

   1. Lambert, Martin
   2. Naber, Dieter
   3. Karow, Anne
   4. Huber, Christian G
   5. Köhler, Jürgen
   6. Heymann, Joachim
   7. Schimmelmann, Benno G

   2009 - Forschungsinformationssystem des UKE
9. Long-term patterns of subjective wellbeing in schizophrenia: cluster, predictors of cluster affiliation, and their relation to recovery criteria in 2842 patients followed over 3 years.

   1. Lambert, Martin
   2. Schimmelmann, Benno Graf
   3. Schacht, Alexander
   4. Karow, Anne
   5. Wagner, Thomas
   6. Wehmeier, Peter M
   7. Huber, Christian G

   2009 - Forschungsinformationssystem des UKE
10. Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorder.

    1. Lambert, Martin
    2. Huber, Christian
    3. Naber, Dieter
    4. Schacht, A
    5. Wagner, T T
    6. Hundemer, H-P
    7. Karow, Anne

    2008 - Forschungsinformationssystem des UKE
11. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia.

    1. Lambert, Martin
    2. Naber, Dieter
    3. Schacht, A
    4. Wagner, T
    5. Hundemer, H-P
    6. Karow, Anne
    7. Huber, Christian

    2008 - Forschungsinformationssystem des UKE
12. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia.

    1. Karow, Anne
    2. Czekalla, Joerg
    3. Dittmann, Ralf W
    4. Schacht, Alexander
    5. Wagner, Thomas
    6. Lambert, Martin
    7. Schimmelmann, Benno Graf

    2007 - Forschungsinformationssystem des UKE
13. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia.

    1. Lambert, Martin
    2. Schimmelmann, Benno G
    3. Naber, Dieter
    4. Schacht, Alexander
    5. Karow, Anne
    6. Wagner, Thomas
    7. Czekalla, Joerg

    2006 - Forschungsinformationssystem des UKE
14. Subjective well-being under the neuroleptic treatment and its relevance for compliance.

    1. Naber, Dieter
    2. Karow, Anne
    3. Lambert, Martin

    2005 - Forschungsinformationssystem des UKE
15. [Subjective well-being under antipsychotic treatment and its meaning for compliance and course of disease]

    1. Naber, Dieter
    2. Lambert, Martin
    3. Karow, Anne

    2004 - Forschungsinformationssystem des UKE
16. Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.

    1. Lambert, Martin
    2. Conus, P
    3. Eide, P
    4. Mass, R
    5. Karow, Anne
    6. Moritz, Steffen
    7. Golks, D

    2004 - Forschungsinformationssystem des UKE
17. Comorbidity of schizophrenia and galactosemia: effective clozapine treatment with weight gain.

    1. Haasen, Christian
    2. Lambert, Martin
    3. Yagdiran, Oktay
    4. Karow, Anne
    5. Krausz, Michael
    6. Naber, Dieter

    2003 - Forschungsinformationssystem des UKE
18. Subjective well-being and initial dysphoric reaction under antipsychotic drugs - concepts, measurement and clinical relevance.

    1. Lambert, Martin
    2. Schimmelmann, B Graf
    3. Karow, Anne
    4. Naber, Dieter

    2003 - Forschungsinformationssystem des UKE